摘要
目的分析冠心病患者患者行经皮冠状动脉介入治疗(PCI)的临床效果。方法将南阳市中心医院2021年2月至2023年3月收治的冠心病患者(82例)作为研究对象,依据区间随机法将其分为对照组、研究组,各41例,对照组行常规药物治疗,研究组予以常规药物+PCI治疗。比较两组治疗有效率,治疗前后心功能指标,内皮功能指标及胸痛患者危险分层及预测预后的危险评分(TIMI)。结果研究组治疗有效率(97.56%)高于对照组(80.49%),差异具有统计学意义(P<0.05);治疗前两组心功能指标、内皮功能指标对比差异无统计学意义(P>0.05),治疗后研究组各心功能指标、内皮功能指标均优于对照组,差异均有统计学意义(P<0.05);治疗前两组TIMI评分对比差异无统计无意义(P>0.05),治疗后研究组TIMI评分低于对照组,差异具有统计学意义(P<0.05)。结论冠心病患者采用PCI治疗可取得较理想的治疗效果,可显著改善患者心功能与预后,值得应用。
Objective To explore the application effects of percutaneous coronary intervention(PCI)on the treatment of coronary heart disease.Methods A total of 82 coronary heart disease patients treated from February 2021 to March 2023 in Nanyang Central Hospital were chosen as research subjects.According to the random interval method,patients were assigned to control group and research group,with 41 cases in each group,The routine drug therapy was applied in the control group;the routine drug therapy and PCI were applied in the research group.Comparison of treatment efficacy,pre-and post-treatment cardiac function indicators,endothelial function indicators,risk stratification of chest pain patients,and risk score for predicting prognosis between two groups(TIMI).Results The total effective rates in the research group(97.56%)were higher than control group(80.49%),the difference is statistically significant(P<0.05);before treatment,the cardiac function indicators and endothelial function indicators between groups were not significantly different(P>0.05);after treatment,the research group had better cardiac and endothelial function indicators than the control group,and the differences were statistically significant(P<0.05);before treatment,TIMI scores between groups were not significantly different(P>0.05);after treatment,TIMI scores in the research group were lower than control group,the difference is statistically significant(P<0.05).Conclusion PCI treatment for coronary heart disease patients can achieve ideal therapeutic effects,significantly improve patient cardiac function and prognosis,and is worth applying.
作者
侯万鑫
侯万聪
HOU Wanxin;HOU Wancong(Cardiovascular Interventional Surgery Room,Nanyang Central Hospital,Nanyang Henan 473000,China;Department of Third Oncology,Nanyang First People’s Hospital,Nanyang Henan 473000,China)
出处
《临床研究》
2024年第3期34-37,共4页
Clinical Research
关键词
经皮冠状动脉介入治疗
冠心病
心功能
内皮功能
percutaneous coronary intervention
coronary heart disease
cardiac function
endothelial function
作者简介
侯万鑫,女,住院医师,本科。研究方向:冠脉造影及支架置入术方面。
